宿主環境因子

REFERENCES–宿主環境因子

• Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321-330.
• Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415-421.
• Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56-61.
• National Cancer Institute. Microbiome. NCI Dictionary of Cancer Terms. www.cancer.gov/publications/dictionaries/cancer-terms/def/microbiome. Accessed May 10, 2018.
• Zitvogel L, Galluzzi L, Viaud S, et al. Cancer and the gut microbiota: an unexpected link. Sci Transl Med. 2015. doi10.1126/scitranslmed. 3010473.
• Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science. 2018;359(6371):91-97.
• Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97-103.
• Kaiser J. Gut microbes shape response to cancer immunotherapy. Science. 2017;358(6363):573.
• Li Q, Gao Z, Wang H, et al. Intestinal immunomodulatory cells (T lymphocytes): a bridge between gut microbiota and diabetes. Mediators Inflamm. 2018. doi:10.1155/2018/9830939.
• Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun. 2016;469(4):967-977.
• Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett C, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804-810.